Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $53.00 price target on Pfizer (NYSE: PFE) after speaking with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Popular stocks with increasing volume: PFE SPCE SNAP NIO AAL FJuly 23, 2020 1:46 AM Transgene Reports Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-Positive CancersJuly 22, 2020 10:51 AM Popular stocks with increasing volume: PFE SNAP TSLA MSFT AAPL AMD NIO SPOT July 22, 2020 9:45 AM Pre-Open Stock Movers 07/22: (NAVI) (BNTX) (WTRH) Higher; (CASI) (SNAP) (COF) Lower (more...)July 22, 2020 9:23 AM U.S. to pay Pfizer, BioNTech $1.95 billion for COVID-19 vaccineJuly 22, 2020 7:18 AM Pfizer (PFE) and BioNTech (BNTX) Announce Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2July 22, 2020 7:11 AM Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2July 22, 2020 7:11 AM U.S. in Pact with Pfizer (PFE) for 100 Million Covid-19 Vaccine Doses - BloombergJuly 22, 2020 7:10 AM Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2July 22, 2020 7:10 AM Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2July 22, 2020 7:10 AM Wall Street ends choppy session higher on mixed earnings, U.S. stimulus debateJuly 22, 2020 6:44 AM Morgan Stanley Reiterates Equalweight Rating on Pfizer (PFE) Following COVID Vaccine UpdateJuly 21, 2020 8:42 AM